Skip to main content
. 2023 Nov 2;11:1187948. doi: 10.3389/fpubh.2023.1187948

Table 2.

Adverse reaction after COVID-19 vaccine administration among health care professionals in Addis Ababa, Ethiopia.

No Adverse reactions following COVID-19 Frequency
1. Did you experience any adverse reactions?
Yes 142 (51.3%)
No 135 (48.7%)
2. Adverse reactions experienced after vaccine administration
Injection site pain 151 (54.5%)
Headache 114 (41.2%)
Fever 104 (37.5%)
Fatigability and tiredness 94 (33.9%),
Chills 92 (33.2%)
Muscle pain 79 (28.5%)
Decreased sleep quality 34 (12.3%)
Nausea and vomiting 24 (8.7%)
Irritation and skin reaction 19 (6.9%)
Body sweating 12 (4.3%)
Runny nose 25 (9%)
Dyspnea 8 (2.9%)
Chest pain 14 (5.1%)
Sore throat 21 (7.6%)
Cough 28 (10.1%)
3. How soon the symptoms appeared after injection with a COVID-19 vaccine
Up to 4 h 17 (6.1%)
5–8 h 70 (25.3%)
9–12 h 41 (14.8%)
After 24 h 14 (5.1%)
4. How long the symptoms lasted
Less than 1 day 29 (10.5%)
1–3 days 79 (28.5%)
4–7 days 34 (12.3%)
More than 7 days 0
5. Have you been diagnosed with any types of thrombosis (blood clots)?
Yes 2 (1.4%)
No 140 (98.6%)
6. Would you recommend the vaccine that you received to others?
Yes 245 (88.4%)
No 32 (11.6%)